{
  "documentMetadata": {
    "title": "Bite wound from Monkey or other Primates",
    "sourceFile": "Bite_ Monkey, Other Primates.pdf",
    "lastUpdated": "2025-01-06"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Viral infection most concerning; fatal human cases of myelitis and hemorrhagic encephalitis have been reported following bites, scratches, or eye inoculation of saliva from monkeys. Herpes B virus found in macaque monkeys, including rhesus macaques, pig-tailed macaques, and cynomolgus monkeys.",
        "Initial symptoms include fever, headache, myalgias and diffuse adenopathy, incubation period of 2-14 days (Emerg Infect Dis 9:246, 2003).",
        "Bacterial infections also occur.",
        "First aid is critical following a monkey bite. Aggressive cleansing of bite wound. Wounds to the head, neck or torso are at greatest risk for rapid spread to CNS; therefore post-exposure prophylaxis (PEP) is indicated.",
        "Note: PEP should be offered in every case of bite exposure because risk is always greater than zero."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Viral: Herpes simiae also referred to as Herpes B, Monkey B Virus, herpesvirus B"
        },
        {
          "type": "paragraph",
          "text": "Bacteria:"
        },
        {
          "type": "list",
          "items": [
            "Haemophilus sp.",
            "Fusobacterium nucleatum",
            "Peptostreptococcus micros, now Peptoniphilus micros",
            "Actinomyces sp.",
            "Oral streptococci",
            "Black-pigmented anaerobic rods",
            "Aggregatibacter actinomycetemcomitans",
            "Wolinella sp.",
            "Campylobacter sp.",
            "Capnocytophaga sp.",
            "Eikenella corrodens",
            "Spirochetes"
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Viral (Herpes B)"
        },
        {
          "type": "nestedContent",
          "content": [
            {
              "type": "paragraph",
              "text": "Post-exposure prophylaxis"
            },
            {
              "type": "drugRegimen",
              "regimenData": {
                "components": [
                  {
                    "drug": "Valacyclovir",
                    "dose": "1 gm",
                    "route": "po",
                    "frequency": "q8h"
                  }
                ],
                "durationDetail": {
                  "fixedDuration": "14 days"
                }
              }
            },
            {
              "type": "drugRegimen",
              "regimenData": {
                "components": [
                  {
                    "drug": "Acyclovir",
                    "dose": "800 mg",
                    "route": "po",
                    "frequency": "5 x/day"
                  }
                ],
                "durationDetail": {
                  "fixedDuration": "14 days"
                }
              }
            }
          ]
        },
        {
          "type": "nestedContent",
          "content": [
            {
              "type": "paragraph",
              "text": "Treatment"
            },
            {
              "type": "drugRegimen",
              "regimenData": {
                "condition": "No CNS symptoms",
                "components": [
                  {
                    "drug": "Acyclovir",
                    "dose": "12.5-15 mg/kg",
                    "route": "IV",
                    "frequency": "q8h"
                  },
                  {
                    "connector": "or",
                    "drug": "Ganciclovir",
                    "dose": "5 mg/kg",
                    "route": "IV",
                    "frequency": "q12h"
                  }
                ]
              }
            },
            {
              "type": "drugRegimen",
              "regimenData": {
                "condition": "CNS symptoms present",
                "components": [
                  {
                    "drug": "Ganciclovir",
                    "dose": "5 mg/kg",
                    "route": "IV",
                    "frequency": "q12h"
                  }
                ]
              }
            }
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Bacterial"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "condition": "Early wound, no sign of infection",
            "components": [
              {
                "drug": "Amoxicillin-clavulanate",
                "dose": "875/125 mg",
                "route": "po",
                "frequency": "bid"
              }
            ],
            "durationDetail": {
              "fixedDuration": "5 days"
            }
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "condition": "Later (3-24 hours), signs of infection",
            "components": [
              {
                "drug": "Ampicillin-sulbactam",
                "dose": "3 gm",
                "route": "IV",
                "frequency": "q6h"
              },
              {
                "connector": "or",
                "drug": "Cefoxitin",
                "dose": "2 gm",
                "route": "IV",
                "frequency": "q8h"
              },
              {
                "connector": "or",
                "drug": "Piperacillin-tazobactam",
                "dose": "4.5 gm",
                "route": "IV",
                "frequency": "q8h",
                "notes": "(over 4 hr)"
              }
            ]
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "condition": "For serious infections, until MRSA is excluded",
            "components": [
              {
                "drug": "Vancomycin",
                "dose": "15-20 mg/kg",
                "route": "IV",
                "frequency": "q8-12h",
                "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator; alternative is trough of 15-20 µg/mL)"
              },
              {
                "connector": "or",
                "drug": "Daptomycin",
                "dose": "6 mg/kg",
                "route": "IV",
                "frequency": "q24h"
              }
            ]
          }
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "list",
      "items": [
        "A carbapenem can be used in place of Ampicillin-sulbactam, Cefoxitin, or Piperacillin-tazobactam if parenteral therapy is required"
      ]
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "condition": "If patient is Penicillin allergic",
        "components": [
          {
            "drug": "Clindamycin"
          },
          {
            "connector": "+",
            "drug": "(Ciprofloxacin or Levofloxacin or Moxifloxacin)"
          }
        ]
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "notes": "where available",
        "components": [
          {
            "drug": "Amoxicillin-clavulanate",
            "dose": "1000 mg-200 mg",
            "route": "IV",
            "frequency": "q8h"
          }
        ]
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Administer tetanus toxoid or Tdap (preferred) if > 10 years since last dose",
        "Rabies in monkeys rare to non-existent but general caution requires PEP after monkey bites in travelers (common occurrence)",
        "See Rabies, Vaccines and PEP for detailed evaluation procedure and recommendations",
        "In vitro Acyclovir and Ganciclovir less active than other nucleosides (Penciclovir or 5-ethyldeoxyuridine may be more active; clinical data needed) (Antimicrob Agents Chemother 51:2028, 2007).",
        "References on treatment and prevention, Clin Infect Dis 20:421, 1995, Clin Infect Dis 35:1191, 2002.",
        "Bacteria similar to human bites, see Clinical Infectious Diseases 2014;59(2):e10-5, Clin Micro Rev, Apr. 2011, p. 231-246."
      ]
    }
  ]
}